Æterna Zentaris Inc

ROBUST AND BALANCED PIPELINE

Click on the product name to link directly to the product sheet.


Drug Discovery	Preclinical	Phase 1	Phase 2	Phase 3	Marketed

120,000 Compounds Library	AEZS-120 Prostate cancer vaccine (oncology) AEZS-136 PI3K/Erk dual inhibitor (oncology) AEZS-125 (LHRH-Disorazol Z) AEZS-137 (Disorazol Z)	AEZS-112 (oncology)	Perifosine Multiple cancers AEZS-108 Ovarian, prostate, bladder and breast cancer Macimorelin acetate (AEZS-130) Therapeutic in tumor induced cachexia and others (endocrinology) Ozarelix (LHRH Antagonist)	AEZS-108 Endometrial cancer Macimorelin acetate (AEZS-130) Diagnostic in adult growth hormone deficiency (endocrinology)	Cetrotide^® in vitro fertilization

Partners			Perifosine: Yakult Honsha Japan Handok Korea (oncology) Hikma Middle East and North Africa	Perifosine: Yakult Honsha Japan Handok Korea (oncology) Hikma Middle East and North Africa	Cetrotide: Merck Serono World ex-Japan Nippon Kayaku / Shionogi Japan

Oncology

Endocrine Therapy

Oncology & Endocrine Therapy

Contact

To inquire about partnering opportunities (in- or out-licensing), please contact our business development group:

Chantal Gravel
Director, Business Operations
Phone: (418) 652-8525
cgravel@aezsinc.com